tiprankstipranks
Trending News
More News >
Althea Group Holdings Ltd. (AU:PKP)
ASX:PKP
Australian Market

Althea Group Holdings Ltd. (PKP) AI Stock Analysis

Compare
15 Followers

Top Page

AU:PKP

Althea Group Holdings Ltd.

(Sydney:PKP)

Select Model
Select Model
Select Model
Underperform 40 (OpenAI - 5.2)
Rating:40Underperform
Price Target:
AU$0.02
Action:DowngradedDate:12/13/25
Althea Group Holdings Ltd. is facing significant financial difficulties, with declining revenues and negative profitability. The technical analysis indicates bearish momentum, and the valuation metrics are concerning due to negative earnings. These factors collectively result in a low overall stock score.
Positive Factors
Free cash flow conversion
Despite overall weak cash generation, the company has shown improving free cash flow growth and a FCF-to-net-income ratio above 1.0, indicating improving efficiency converting earnings into cash. That conversion ability can support near-term operations, reduce reliance on dilutive financing, and provide a firmer base for restructuring or targeted investment if cost control and revenue stabilization continue.
Underlying return on equity
A reported ROE of 14.54% suggests the business can generate returns on capital employed despite balance sheet distortion from negative equity. If solvency is addressed, this level of operating return implies the underlying operations have the potential to be profitable and attract capital or strategic partners, supporting medium-term recovery plans.
Industry structural demand
Operating in the specialty and generic pharmaceuticals sector provides durable structural demand, product lifecycle longevity, and regulatory-driven barriers to entry. These characteristics support more stable revenue streams over months and create opportunities for niche pricing power and recurring sales if the company can restore product supply and commercial execution.
Negative Factors
Declining revenue
A steep revenue decline reduces scale economies, harms bargaining power with suppliers, and undermines fixed-cost absorption. Over the next several months this shrinkage will strain margins and cash, constrain reinvestment in R&D or commercial activity, and make recovery harder without clear new product wins or market-share stabilization.
Deep negative margins
Substantial operating and net losses indicate the company is burning cash on core operations. Persistent negative margins erode equity, limit ability to self-fund operations or growth, and increase dependency on external financing. Without durable margin improvement, liquidity and supplier/customer confidence can deteriorate over the medium term.
Weak balance sheet / negative equity
Negative shareholders' equity and an anomalous debt-to-equity ratio signal potential solvency issues and a fragile capital structure. This condition restricts access to traditional credit, raises the cost of capital, and increases the likelihood of equity raises or restructuring. Such balance-sheet weakness materially elevates execution risk over the coming months.

Althea Group Holdings Ltd. (PKP) vs. iShares MSCI Australia ETF (EWA)

Althea Group Holdings Ltd. Business Overview & Revenue Model

Company DescriptionPeak Processing Limited, together with its subsidiaries, manufactures, distributes, and sells recreational cannabis products in Canada and the United States. The company offers cannabis products, including beverages, hydrocarbon extracts, oils, vapes, oils, topicals, powders, infused flowers, and edibles. It also provides market insights and analysis, product development, manufacturing, commercialization, distribution, and product rework services. The company sells its products through retail stores. The company was formerly known as Althea Group Holdings Limited and change its name to Peak Processing Limited in November 2025. Peak Processing Limited was founded in 2016 and is based in Melbourne, Australia.
How the Company Makes MoneyAlthea Group Holdings Ltd. generates revenue primarily through the sale of its medicinal cannabis products to patients and healthcare providers. The company has established a strong revenue model that includes direct-to-patient sales via its online platform, as well as partnerships with pharmacies and healthcare institutions. Key revenue streams include product sales, subscription models for ongoing patient care, and potential licensing agreements with other cannabis producers or pharmaceutical companies. Additionally, AGH may benefit from government contracts or grants aimed at promoting medicinal cannabis research and accessibility, further enhancing its earnings potential.

Althea Group Holdings Ltd. Financial Statement Overview

Summary
Althea Group Holdings Ltd. faces significant financial challenges, with declining revenues, negative profitability, and a precarious balance sheet. The company needs to address its revenue decline and improve its financial stability to enhance its financial health.
Income Statement
30
Negative
Althea Group Holdings Ltd. has experienced a significant decline in revenue, with a negative revenue growth rate of -37.84% in the latest year. The company also shows negative profitability metrics, including a net profit margin of -53.87% and an EBIT margin of -26.57%. These figures indicate ongoing challenges in achieving profitability and revenue stability.
Balance Sheet
25
Negative
The balance sheet reflects a concerning financial structure, with a negative stockholders' equity and a high debt-to-equity ratio of -9.05. This indicates potential solvency issues and financial instability. The return on equity is positive at 14.54%, but this is due to the negative equity, which distorts the metric.
Cash Flow
35
Negative
Cash flow analysis reveals a negative operating cash flow and free cash flow, although there is a positive free cash flow growth rate of 28.49%. The free cash flow to net income ratio is 1.13, suggesting some efficiency in converting net income to cash, but overall cash flow remains weak.
Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Althea Group Holdings Ltd. Technical Analysis

Technical Analysis Sentiment
Last Price
Price Trends
50DMA
100DMA
200DMA
Market Momentum
MACD
RSI
STOCH
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:PKP, the sentiment is undefined. The current price of undefined is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a undefined sentiment for AU:PKP.

Althea Group Holdings Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison

Althea Group Holdings Ltd. Corporate Events

Peak Processing expands Sweet Justice deal, securing 1.4m-unit annual cannabis beverage output
Mar 2, 2026

Peak Processing Limited has renewed and expanded its manufacturing agreement with Electric Brands Inc., owner of the Sweet Justice cannabis beverage portfolio, reinforcing its role as a scaled producer in the regulated cannabis and hemp-derived drinks segment. The deal covers all Sweet Justice SKUs, maintains annual output at about 1.4 million units, and delivers improved financial terms, enhancing plant utilisation, working capital efficiency, and revenue visibility.

Sweet Justice, one of Canada’s leading independent cannabis beverage brands with growing U.S. distribution in states including Michigan, Florida and North Carolina, remains one of Peak’s largest recurring production programs. Together with recent expansions such as the St. Peter’s Beverages partnership, the renewed contract underscores strong customer retention, platform scalability and Peak’s strategy to leverage automation and proprietary technologies to support further North American expansion.

The most recent analyst rating on (AU:PKP) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Althea Group Holdings Ltd. stock, see the AU:PKP Stock Forecast page.

Peak Processing completes strategic reset to focus on North American THC beverages
Feb 27, 2026

Peak Processing Limited has completed a strategic reset, exiting its legacy UK and Australian medical cannabis operations to concentrate on its North American THC beverage business. The company has overhauled its board and executive team, rebranded, and strengthened its balance sheet through capital raisings to support working capital, production upgrades and operational efficiency.

During the half-year to 31 December 2025, Peak generated customer receipts of $9.35 million and revenue of $5.53 million, while maintaining around a 33% share of the Canadian THC beverage market and a 98% on-time, in-full fulfilment rate. A non-cash goodwill impairment drove a statutory loss, but cost-reduction and rightsizing programs are expected to deliver about $2.6 million in annualised savings, materially lowering fixed overheads.

The company has bolstered revenue visibility with long-term contracts with Organigram Global and New Leaf Canada and a 250% expansion of its manufacturing agreement with St. Peter’s Beverages, which should significantly lift production volumes. In the U.S., Peak produced and sold more than 680,000 cans in the half, secured a long-term deal with Funky Buddha in Florida, and commissioned an emulsion lab for its patent-pending Envision technology to support growth in a rapidly emerging category.

Entering the second half of FY26, Peak reports a strengthening order pipeline ahead of the key summer season and a growing funnel of prospective customers for contract manufacturing. Management believes the structural reset, reduced cost base, improved liquidity and expanding commercial contracts position the company as a focused North American beverage manufacturer with enhanced prospects for near-term growth.

The most recent analyst rating on (AU:PKP) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Althea Group Holdings Ltd. stock, see the AU:PKP Stock Forecast page.

Peak Processing Flags Deeper Half-Year Loss and Going-Concern Risk Amid Restructuring
Feb 27, 2026

Peak Processing Limited reported a steep decline in revenue for the half year ended 31 December 2025, with ordinary activities income falling 47.7% to $5.49 million compared with the prior corresponding period. The group, which consolidates operations in Canada, the United States and Ireland under Australian Accounting Standards, continues to carry negative net tangible assets per share, highlighting balance sheet pressure and an absence of dividend payments.

The company’s loss after tax widened sharply to $5.43 million, driven by an impairment of non-current assets of $4.35 million, partly offset by a $2.55 million profit from discontinued operations arising from accounting gains during an administration process. Control of a subsidiary was temporarily lost due to voluntary administration but was regained before period end, while auditors flagged a material uncertainty related to going concern in their review, underscoring ongoing financial and operational risks for stakeholders.

Net tangible assets per ordinary security improved but remained negative at minus 0.30 cents, compared with minus 0.51 cents a year earlier, reflecting continued erosion of shareholder equity. With no dividends declared and a going-concern uncertainty noted, the half-year results point to a company still navigating restructuring and asset impairment issues, with its future performance and capital structure under close scrutiny by investors and creditors.

The most recent analyst rating on (AU:PKP) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Althea Group Holdings Ltd. stock, see the AU:PKP Stock Forecast page.

Peak Processing Raises $2.72m to Drive North American THC Beverage Growth
Feb 2, 2026

Peak Processing Limited has secured firm commitments from sophisticated and professional investors to raise $2.72 million through a placement of 160 million new shares at $0.017 each, a 10.53% discount to its last closing price. The capital will support increased sales and distribution volumes, production efficiency and margin enhancement initiatives, supply chain optimisation, and general working capital across its Canadian and US operations, with directors and management also participating to demonstrate alignment with shareholders. In addition, the non-executive chair has elected to receive a portion of director fees in shares at the placement price, underscoring leadership confidence in the company’s growth strategy and further tying board remuneration to long-term shareholder outcomes, while the placement’s structure and use of funds aim to accelerate Peak Processing’s expansion and operational scaling in the North American THC beverage market.

The most recent analyst rating on (AU:PKP) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Althea Group Holdings Ltd. stock, see the AU:PKP Stock Forecast page.

Peak Processing Rebrand, Cost Cuts and New Deals Strengthen Cannabis Beverage Platform
Feb 1, 2026

Peak Processing Limited reported a pivotal December 2025 quarter marked by a full corporate rebrand, operational streamlining and expanded commercial partnerships that bolster its position in the regulated cannabis beverages market. The company delivered strong manufacturing performance with on-time, in-full metrics above 99% and 3.7 million cans produced in 2025, implemented an organisational restructure expected to generate about $1.35 million in annualised cost savings, and advanced automation to improve throughput and quality. New long-term manufacturing agreements with Organigram Global and New Leaf Canada, 21 new product listings across key Canadian provinces for 2026, and broader use of its Envision Emulsions platform by 15 brand partners have strengthened revenue visibility and production scale. Peak also deepened its branded footprint via the growth of JUST Seltzers and Snap Back, re-entered the cannabis topicals category through the LivRelief Infused partnership, and signed a strategic distribution deal with EXKA to launch the French-language JUSTE Seltzer brand in Québec, moves that collectively expand its market reach and support sustainable growth while ongoing capital management efforts aim to reinforce liquidity into the first half of 2026.

The most recent analyst rating on (AU:PKP) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Althea Group Holdings Ltd. stock, see the AU:PKP Stock Forecast page.

Peak Processing Secures Trading Halt Ahead of Proposed Capital Raise
Jan 28, 2026

Peak Processing Limited has requested and been granted a trading halt on its quoted securities on the ASX, effective immediately and remaining in place until either the release of a pending announcement or the commencement of normal trading on 2 February 2026. The halt is tied to a proposed capital raise and is intended to help the company manage its continuous disclosure obligations, signaling that Peak Processing may be preparing to strengthen its balance sheet or fund new initiatives, with potential implications for existing shareholders once full details are released.

The most recent analyst rating on (AU:PKP) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Althea Group Holdings Ltd. stock, see the AU:PKP Stock Forecast page.

Peak Processing triples cannabis beverage SKUs under expanded St. Peter’s deal
Jan 22, 2026

Peak Processing has expanded its manufacturing partnership with St. Peter’s Beverages, securing a multiyear, exclusive Canadian manufacturing agreement for all remaining Cookies beverages and the full Green Monké range. The deal lifts Peak’s production mandate from 4 to 14 SKUs, translating into an estimated additional 500,000 to 700,000 units annually and materially higher revenue, while also adding income from logistics, storage and testing services. All new SKUs will use Peak’s patent-pending Envision Emulsions platform, deepening its technology-led positioning in regulated THC beverages and strengthening ties with well-known North American brands whose US distribution, including Green Monké’s rollout through Circle K stores, enhances Peak’s exposure to the US market and supports its broader North American growth strategy.

The most recent analyst rating on (AU:PKP) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Althea Group Holdings Ltd. stock, see the AU:PKP Stock Forecast page.

Peak Processing Restructures Finance Function as CFO Departs
Jan 19, 2026

Peak Processing Limited has announced the immediate departure of its Canadian-based Chief Financial Officer, Brian Mbesha, as part of an internal restructure of its finance function linked to a broader cost optimisation program. The company will maintain financial oversight and reporting through its existing finance team, supported on an interim part-time basis by an Australian external professional services firm to handle CFO responsibilities, with the board stating that the changes are intended to strengthen the cost base while preserving sufficient financial expertise to underpin disciplined growth and improved financial performance.

The most recent analyst rating on (AU:PKP) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Althea Group Holdings Ltd. stock, see the AU:PKP Stock Forecast page.

Peak Processing Limited Announces Director’s Interest Change
Dec 16, 2025

Peak Processing Limited has announced a change in the director’s interest, specifically regarding Manik Pujara, who has acquired 6,000,000 options exercisable at $0.025 per option, expiring on December 15, 2027. This acquisition was made through Trinetra Holdings Pty Ltd, where Pujara is a director and beneficiary, and was issued for nil cash consideration, valued at $0.0065 per option. This change follows the passing of Resolution 10 at the company’s 2025 Annual General Meeting, indicating strategic financial maneuvers that could impact the company’s market positioning and shareholder interests.

The most recent analyst rating on (AU:PKP) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Althea Group Holdings Ltd. stock, see the AU:PKP Stock Forecast page.

Peak Processing Limited Announces Director’s Interest Change
Dec 16, 2025

Peak Processing Limited announced a change in the director’s interest, with Matt Adams acquiring 7,000,000 options exercisable at $0.025 each, expiring in December 2027. This issuance, valued at approximately $45,500, follows the passing of a resolution at the company’s 2025 Annual General Meeting, potentially impacting the company’s governance and shareholder dynamics.

The most recent analyst rating on (AU:PKP) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Althea Group Holdings Ltd. stock, see the AU:PKP Stock Forecast page.

Peak Processing Limited Issues 13 Million Unquoted Equity Options
Dec 16, 2025

Peak Processing Limited announced the issuance of 13,000,000 unquoted equity securities in the form of options expiring on December 15, 2027, with an exercise price of $0.025. This issuance is part of an employee incentive scheme and is not intended to be quoted on the ASX, potentially impacting the company’s employee retention and motivation strategies.

The most recent analyst rating on (AU:PKP) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Althea Group Holdings Ltd. stock, see the AU:PKP Stock Forecast page.

Peak Processing Secures Key Agreement with Organigram for THC Beverages
Dec 11, 2025

Peak Processing Limited has signed a two-year Beverage Fulfillment Agreement with Organigram Inc., a major Canadian cannabis producer, to manufacture the Collective Project brand of THC-infused beverages. This agreement is expected to enhance Organigram’s expansion into the beverage category and solidify Peak’s role as a leading manufacturer in the fast-growing THC beverage market. The collaboration aims to ensure consistent manufacturing and supply continuity while leveraging Organigram’s innovations and Peak’s production scale. The agreement is seen as a strategic move to boost Peak’s operational momentum and revenue profile, reinforcing its position as a trusted manufacturing partner for cannabis beverage brands in Canada.

The most recent analyst rating on (AU:PKP) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Althea Group Holdings Ltd. stock, see the AU:PKP Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 13, 2025